Season: Season 2

Luke focuses his practice on corporate and securities matters, transactions, and general corporate matters. He counsels companies of all sizes, from start-ups to public companies, in a variety of industries, including health care, artificial intelligence, technology, and life sciences.
Before joining Mintz, Luke worked on the Quebec Investment Team of a Canada-wide venture capital fund dedicated to investing in student-founded start-ups. He also researched the impact of artificial intelligence on access to justice at the Montreal-based Cyberjustice Laboratory. Upon completing his legal studies, he interned with Global Affairs Canada’s Trade Law Bureau, where he reviewed international investment treaties and advised on bilateral trade agreement negotiations.
During law school, Luke worked on a number of commercial transactions involving infrastructure, public-private partnerships, and start-up financing as a summer associate at major Canadian law firms. Additionally, Luke served as a judicial clerk at the Superior Court of Québec and as a legal intern with the US Library of Congress.
Prior to his legal studies, Luke conducted clinical research in thoracic surgery and respirology at Toronto General Hospital and McGill University Health Centre and coauthored several high-impact publications.

Stephanie Mouchbahani-Constance a venture capital investor at Kli Capital, the venture branch of a family office based in New York which invests in pre-seed and seed startups across all industries. She is the former CEO and co-founder of a consumer biotech startup which she co-founded while completing her PhD in Neurophysiology at McGill University. She successfully brought her product from the lab to market in 1 year and commercialized it across the US. Stephanie then coached healthcare and biotech startups at District 3 Innovation Center in their validation program before beginning her career in venture capital.

Richard Skaife is a Partner at The Conscious Fund ( an investor in Microdose and most of the well known companies in the psychedelic medicine space) and a Co Founding Partner at Longr a longevity platform company focused on access. He’s served as a partner in European tier 1 VC funds and as a CEO in a venture studio that launched Digipill ( a multi million downloaded mental health app ) and Pollen VC a mobile focused fintech.

Today, we’re excited to have a truly remarkable guest with us—Anarghya Vardhana, General Partner at Maveron.
Anarghya has an incredible track record in venture capital, focusing on consumer brands that are reshaping healthcare and wellness. Her portfolio includes investments in pioneering companies like Alife, Bend Health, Caraway Health, and Goodbill, all of which are making significant strides in mental health, women’s health, and healthcare platforms.

Before joining Maveron, Anarghya made a name for herself in the Bay Area tech scene with roles at Google, Medable, and several other startups. A Stanford graduate, she has also earned accolades such as Forbes ’30 Under 30′ and the Diversity Champion Award from Forbes and JP Morgan Chase.

In addition to her work as an investor, Anarghya is a passionate advocate for diversity in venture capital, a Kauffman Fellow, and an active participant in All Raise. We are thrilled to dive into her journey, explore the future of healthcare investment, and hear her insights on what it takes to build iconic consumer brands in the health and wellness space.

In this episode of Business of HLTH, we sit down with Robin Arnott, CEO of SoundSelf, and Dr. Sandeep Prakash, Chief Scientific Officer, to explore the future of digital therapeutics and their revolutionary approach to mental health care. SoundSelf is at the forefront of blending immersive technology with therapeutic practices, offering a unique platform that combines sound, light, and voice-driven biofeedback to help users achieve deep meditative states—often comparable to a psychedelic experience within just 15 minutes.
Robin shares his journey from the gaming industry to creating a digital platform that merges modern technology with the wisdom of ancient spiritual practices. Dr. Sandeep delves into the scientific foundations of SoundSelf, including how the technology utilizes biofeedback and neurostimulation to facilitate profound mental shifts, enhance neuroplasticity, and support therapies like ketamine-assisted sessions.
Together, they address the potential and challenges of integrating digital tools in a clinical setting, the role of digital therapeutics in expanding access to mental health care, and how SoundSelf’s carefully designed experiences are making a difference for both patients and practitioners. Whether you’re a healthcare professional, a tech enthusiast, or curious about the evolving field of mental health, this episode offers valuable insights into the intersection of technology and therapy.
Tune in to learn how SoundSelf is redefining what’s possible in the realm of mental wellness. For more information, visit soundself.com.